This is the authors' abstract. We don't add key points for this paper.
Worldwide, the simultaneous occurrence of sellar gangliocytoma with pituitary adenoma is rarely reported. Herein we describe a unique case of mixed gangliocytoma-pituitary adenoma of dual lineage. A 45-year-old male presented with transient ischemic attack, right sided numbness and decreased vision. Endocrinological examination found prolactin level to be elevated. Imaging studies revealed a 2.8 cm sellar/suprasellar lesion with superior displacement of optic chiasm. The patient underwent tumor resection via trans-naso-sphenoid approach. Histologic sections show a biphasic tumor with two populations of cells, mature ganglion cells and prolactin secreting neuroendocrine cells. The tumor has unique dual lineage with one dominant expression of pituitary-specific transcription factor (PIT1) in all cell components which matched closely to prolactin positivity. By Immunohistochemistry, a less prominent but obvious component of Scattered steroidogenic factor 1 (SF1) positive cells were identified, although follicle stimulating hormone (FSH) and luteinizing hormone (LH) were negative. T- box transcription factor (TPIT) stain was negative. Accordingly, the diagnosis of mixed gangliocytoma-pituitary adenoma of dual lineage was established.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Obiedat et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: